ZIDOVUDINE INDUCES THE EXPRESSION OF CELLULAR-RESISTANCE AFFECTING ITS ANTIVIRAL ACTIVITY

被引:49
作者
DIANZANI, F
ANTONELLI, G
TURRIZIANI, O
RIVA, E
SIMEONI, E
SIGNORETTI, C
STROSSELLI, S
CIANFRIGLIA, M
机构
[1] UNIV PISA,DEPT BIOMED,I-56100 PISA,ITALY
[2] IST SUPER SANITA,CELLULAR BIOL LAB,I-00161 ROME,ITALY
[3] CNR,IST GENET BIOCHIM & EVOLUZIONIST,I-27100 PAVIA,ITALY
关键词
D O I
10.1089/aid.1994.10.1471
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that multidrug-resistant cells expressing the multidrug transporter P-glycoprotein are less sensitive to the antiviral activity of AZT. Subsequently, we addressed the question whether AZT itself is able to induce cellular resistance to the drug. Indeed, CEM cells propagated in the presence of increasing concentrations of AZT become resistant to the antigrowth and antiviral activity of AZT but do not express detectable level of P-glycoprotein. Sensitivity of these cells to other compounds, such as vinblastine, vincristine, ddI, and ddC remained unchanged, indicating that, in contrast to P-glycoprotein-positive cells, AZT-induced resistance is specific for AZT. Interestingly, in AZT-induced resistant cells the intracellular accumulation of AZT and exogenous deoxythymidine, as well as thymidine kinase activity, are significantly reduced when compared with the parental cell line. Our findings show that AZT itself may directly induce the expression of cellular mechanisms leading to the acquisition of specific cellular resistance that can affect its antiviral activity.
引用
收藏
页码:1471 / 1478
页数:8
相关论文
共 30 条
[1]   RESISTANCE OF HIV-1 TO AZT MIGHT ALSO INVOLVE THE CELLULAR EXPRESSION OF MULTIDRUG RESISTANCE P-GLYCOPROTEIN [J].
ANTONELLI, G ;
TURRIZIANI, O ;
CIANFRIGLIA, M ;
RIVA, E ;
DONG, G ;
FATTOROSSI, A ;
DIANZANI, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) :1839-1844
[2]  
AVRAMIS VI, 1993, J ACQ IMMUN DEF SYND, V6, P1287
[3]   ADENOSINE TRIPHOSPHATE-DEPENDENT TRANSPORT OF DOXORUBICIN, DAUNOMYCIN, AND VINBLASTINE IN HUMAN TISSUES BY A MECHANISM DISTINCT FROM THE P-GLYCOPROTEIN [J].
AWASTHI, S ;
SINGHAL, SS ;
SRIVASTAVA, SK ;
ZIMNIAK, P ;
BAJPAI, KK ;
SAXENA, M ;
SHARMA, R ;
ZILLER, SA ;
FRENKEL, EP ;
SINGH, SV ;
HE, NG ;
AWASTHI, YC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :958-965
[4]  
BECK WT, 1979, CANCER RES, V39, P2070
[5]   ZIDOVUDINE SENSITIVITY OF HUMAN IMMUNODEFICIENCY VIRUSES FROM HIGH-RISK, SYMPTOM-FREE INDIVIDUALS DURING THERAPY [J].
BOUCHER, CAB ;
TERSMETTE, M ;
LANGE, JMA ;
KELLAM, P ;
DEGOEDE, REY ;
MULDER, JW ;
DARBY, G ;
GOUDSMIT, J ;
LARDER, BA .
LANCET, 1990, 336 (8715) :585-590
[6]   MECHANISM OF MULTIDRUG RESISTANCE [J].
BRADLEY, G ;
JURANKA, PF ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :87-128
[7]   ISOLATION AND CHARACTERIZATION OF THYMIDINE TRANSPORT MUTANTS OF CHINESE HAMSTER CELLS [J].
BRESLOW, RE ;
GOLDSBY, RA .
EXPERIMENTAL CELL RESEARCH, 1969, 55 (03) :339-&
[8]   CHARACTERIZATION BY SOMATIC-CELL GENETICS OF A MONOCLONAL-ANTIBODY TO THE MDR1 GENE-PRODUCT (P-GLYCOPROTEIN) - DETERMINATION OF P-GLYCOPROTEIN EXPRESSION IN MULTI-DRUG-RESISTANT KB AND CEM CELL VARIANTS [J].
CENCIARELLI, C ;
CURRIER, SJ ;
WILLINGHAM, MC ;
THIEBAUT, F ;
GERMANN, UA ;
RUTHERFORD, AV ;
GOTTESMAN, MM ;
BARCA, S ;
TOMBESI, M ;
MORRONE, S ;
SANTONI, A ;
MARIANI, M ;
RAMONI, C ;
DUPUIS, ML ;
CIANFRIGLIA, M .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (04) :533-543
[9]  
CIANFRIGLIA M, 1994, J CANCER, V56, P153
[10]  
CLOUSE KA, 1989, J IMMUNOL, V142, P431